AgingResearch.NewsJoin free

United Therapeutics

CompanyUnited StatesFounded 1996

Wikidata

United Therapeutics develops one asset, in phase 3 (treprostinil in idiopathic pulmonary fibrosis). Mostly small molecule acting on PTGIR; based in the United States, founded in 1996.

1
Asset
Furthest stage
Phase 3
6
Trials
0
Signals

Pipeline

1

  • treprostinil

    Prostacyclin analogue that promotes vasodilation and inhibits vascular proliferation and fibrosis.

    Phase 3, Small molecule, PTGIR, idiopathic pulmonary fibrosis, interstitial lung disease

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials9
  • Similar companies6

Intelligence